Supplementary Tables S1-S8 from 17-Hydroxy Wortmannin Restores TRAIL's Response by Ameliorating Increased Beclin 1 Level and Autophagy Function in TRAIL-Resistant Colon Cancer Cells

Sheng Dai,Shu Yang,Xin Hu,Wei Sun,Gregory Tawa,Wenge Zhu,Aaron D. Schimmer,Chao He,Bingliang Fang,Hongbo Zhu,Wei Zheng

DOI: https://doi.org/10.1158/1535-7163.22507303

2023-01-01

Abstract:Supplementary Table S1. Summary of the antibodies used in experiments; Supplementary Table S2. List of compounds confirmed in the high throughput screening with DLD1-R cells; Supplementary Table S3. BECN1 knockdown re-sensitize DLD1-R cells to TRAIL; Supplementary Table S4. IC50 of TRAIL treatment in each cell line; Supplementary Table S5. 17-HW re-sensitizes multiple colon cancer cell lines to TRAIL; Supplementary Table S6. BECN1 knockdown re-sensitize multiple colon cancer cell lines to TRAIL; Supplementary Table S7. Patient demographics and baseline characteristics; Supplementary Table S8. Clinicopathological factors and their relationship to the expression of beclin1 and caspase-8